|
IQCG–NUP98
(HGNC:25251, HGNC:8068)
|
leukemia
(MONDO_0005059)
|
weak |
weak |
weak |
weak |
weak |
|
|
DAZAP1–MEF2D
(HGNC:2683, HGNC:6997)
|
MONDO:0004967
(MONDO:0004967)
|
strong |
weak |
weak |
moderate |
weak |
|
|
DAXX–ATRX
(HGNC:2681, HGNC:886)
|
gastrointestinal stromal tumor
(MONDO_0011719)
|
weak |
weak |
weak |
weak |
weak |
|
|
POU2AF3–EWSR1
(HGNC:26978, HGNC:3508)
|
MONDO:0005089
(MONDO:0005089)
|
strong |
weak |
moderate |
strong |
weak |
|
|
CTSC–RAB38
(HGNC:2528, HGNC:9776)
|
MONDO:0007154
(MONDO:0007154)
|
moderate |
moderate |
moderate |
moderate |
weak |
|
|
CLIP2–MET
(HGNC:2586, HGNC:7029)
|
MONDO:0016729
(MONDO:0016729)
|
moderate |
weak |
weak |
moderate |
weak |
|
|
CYP2E1–MTG1
(HGNC:2631, HGNC:32159)
|
|
strong |
weak |
weak |
strong |
weak |
|
|
CYP11B1–CYP11B2
(HGNC:2591, HGNC:2592)
|
congenital adrenal hyperplasia
(MONDO_0018479)
|
weak |
weak |
weak |
weak |
weak |
|
|
BCORL1–JAZF1
(HGNC:25657, HGNC:28917)
|
MONDO:0007886
(MONDO:0007886)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
CTNNB1–PLAG1
(HGNC:2514, HGNC:9045)
|
MONDO:0008401
(MONDO:0008401)
|
strong |
weak |
moderate |
strong |
weak |
|
|
KIAA1217–RET
(HGNC:25428, HGNC:9967)
|
non-small cell lung carcinoma
(MONDO_0005233)
|
strong |
strong |
moderate |
strong |
weak |
|
|
CUX1–NUTM1
(HGNC:2557, HGNC:29919)
|
MONDO:0004947
(MONDO:0004947)
|
moderate |
weak |
moderate |
moderate |
weak |
|
|
KNL1–KMT2A
(HGNC:24054, HGNC:7132)
|
acute myeloid leukemia with minimal differentiation
(MONDO_0005223)
|
moderate |
weak |
moderate |
moderate |
weak |
|
|
GREB1–NCOA2
(HGNC:24885, HGNC:7669)
|
MONDO:0005089
(MONDO:0005089)
|
strong |
weak |
moderate |
strong |
weak |
|
|
SH3PXD2A–HTRA1
(HGNC:23664, HGNC:9476)
|
MONDO:0002546
(MONDO:0002546)
|
strong |
strong |
moderate |
strong |
weak |
|
|
GREB1–CTNNB1
(HGNC:24885, HGNC:2514)
|
MONDO:0003311
(MONDO:0003311)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
WWTR1–FOSB
(HGNC:24042, HGNC:3797)
|
MONDO:0003945
(MONDO:0003945)
|
moderate |
weak |
weak |
strong |
weak |
|
|
ACKR3–HMGA2
(HGNC:23692, HGNC:5009)
|
MONDO:0005106
(MONDO:0005106)
|
moderate |
weak |
weak |
strong |
weak |
|
|
CREB3L2–FUS
(HGNC:23720, HGNC:4010)
|
low grade fibromyxoid sarcoma
(MONDO_0006272)
|
strong |
weak |
moderate |
strong |
weak |
|
|
CREM–FUS
(HGNC:2352, HGNC:4010)
|
|
weak |
weak |
weak |
moderate |
weak |
|